Vivani Medical (NASDAQ:VANI - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.02), Zacks reports.
Vivani Medical Stock Down 0.8%
Shares of VANI stock opened at $1.26 on Thursday. Vivani Medical has a 12 month low of $0.91 and a 12 month high of $1.80. The firm has a market cap of $74.64 million, a PE ratio of -2.93 and a beta of 2.99. The stock has a 50 day moving average of $1.34 and a 200-day moving average of $1.18.
Wall Street Analyst Weigh In
Separately, HC Wainwright reiterated a "buy" rating and set a $4.00 price target on shares of Vivani Medical in a report on Monday, May 19th.
Get Our Latest Analysis on VANI
About Vivani Medical
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Read More
Before you consider Vivani Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.
While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access